Eradikation des Hepatitis C Virus bei Dialysepatienten mit Grazoprevir und Elbasvir

Translated title of the contribution: Grazoprevir plus elbasvir in treatmentnaive and treatment-experienced patient with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): A combination phase 3 study

David Roth, D. R. Nelson, A. Bruchfeld, A. Liapakis, M. Silva, H. Monsour, P. Martin, S. Pol, M. C. Londoño, T. Hassanein, P. J. Zamor, E. Zuckerman, S. Wan, B. Jackson, B. Y. Nguyen, M. Robertson, E. Barr, J. Wahl, W. Greaves

Research output: Contribution to journalShort surveypeer-review

Fingerprint Dive into the research topics of 'Grazoprevir plus elbasvir in treatmentnaive and treatment-experienced patient with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): A combination phase 3 study'. Together they form a unique fingerprint.